Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)

Study acronym: AVATAR
StatusUnknown
PhaseNot applicable
Started

Record status This record was last updated December 4, 2024 (before its estimated October 19, 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Site contacts updated at 1 of 5 sitesv4
  3. Study sites: 4 to 5
    • Secondary endpoints revised (13)
    • Study title expanded, about 1 word
    v3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Sep 1, 2025 to Oct 19, 2025
    • Study completion date: Sep 8, 2025 to Oct 26, 2025
    • Start date changed from estimate of Sep 1, 2023 to Oct 19, 2023
    • Site details revised at 4 of 4 sites
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Bronchial fibroscopy (BF) is a routine practice examination in critical care areas. It can be useful either for the diagnosis of the causal pathology of respiratory distress or for the diagnosis of lung infection, sometimes nosocomial. In patients in spontaneous and conscious ventilation, BF are performed vigil after local anesthesia according to the recommendations of the Société de Pneumologie de langue Française. The good tolerance of the examination and its good conduct may require the use of anxiolytics, sedatives or analgesics to limit the traumatic experience of a highly anxiety-provoking examination. Virtual reality (VR) combines a set of paramedical techniques (hypnosis, music therapy, sophrology) and is now a non-drug alternative to improve the tolerance of certain invasive gestures.VR has been shown to reduce pain and anxiety during first pathways placement or digestive endoscopies. To date, there is no evidence of the benefit of VR when performing semi-urgent BF in critical care areas.
Trial Details
NCT Number NCT05973201
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: Ministry of Health, France
Conditions
(from sponsor)		 Respiratory Disorder, Lung Infection
Related terms Anxiety Disorders, Pain, Respiration Disorders
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov